LVAD Woes: Lub-Dub, Lub-Dub, Lub-Dub…or Maybe Not!

  • Nick KmanEmail author
  • Leslie Adrian


Left ventricular assist devices (LVADs) are designed to assist left ventricular output in patients with severe cardiomyopathy. There are two types of LVADs: pulsatile flow and continuous flow. As with any implantable device, there is always a risk of complications. Some common complications include ventricular arrhythmias, infections, stroke, worsening heart failure, and bleeding from anticoagulation. Additionally, although reliable, the devices can malfunction or become thrombosed. LVAD patients can be complex and early involvement of the LVAD team that normally cares for the patient can be helpful.


LVAD, left ventricular assist device Driveline Congestive heart failure Cardiomyopathy 


Disclosure Statement

The authors of this chapter report no significant disclosures.


  1. 1.
    Fitzgibbon J, Kman NE, Gorgas D. Asymptomatic sustained polymorphic ventricular tachycardia in a patient with a left ventricular assist device: case report and what the emergency physician should know. J Emerg Med. 2016;50:E135–41.CrossRefGoogle Scholar
  2. 2.
    Baughman K, Jarcho J. Bridge to life - cardiac mechanical support. N Engl J Med. 2007;357(9):846–9.CrossRefGoogle Scholar
  3. 3.
    Mehra MR, Goldstein DJ, Uriel N, et al. Two-Year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2018;378:1386–95.CrossRefGoogle Scholar
  4. 4.
    Ammar K, Jacobsen S, Mahoney D, Kors J, Redfield M, Burnett J, et al. Prevalence and prognostic significance of heart failure stages - application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation. 2007;115(12):1563–70.CrossRefGoogle Scholar
  5. 5.
    Al Danaf J, Butler J, Yehya A. Updates on device-based therapies for patients with heart failure. Curr Heart Fail Rep. 2018;15(2):53–60.CrossRefGoogle Scholar
  6. 6.
    McIlvennan C, Magid K, Ambardekar A, Thompson J, Matlock D, Allen L. Clinical outcomes after continuous-flow left ventricular assist device: a systematic review. Circ Heart Fail. 2014;7(6):1003–237.CrossRefGoogle Scholar
  7. 7.
    Miller L, Rogers J. Evolution of left ventricular assist device therapy for advanced heart failure: a review. JAMA Cardiol. 2018;3(7):650–8.CrossRefGoogle Scholar
  8. 8.
    Bedi M, Kormos R, Winowich S, McNamara D, Mathier M, Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99(8):1151–3.CrossRefGoogle Scholar
  9. 9.
    Andersen M, Videbaek R, Boesgaard S, Sander K, Hartsen P, Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant. 2009;28(7):733–5.CrossRefGoogle Scholar
  10. 10.
    Greet BD, Pujara D, Burkland D, Pollet M, Sudhakar D, Rojas F, Costello B, Postalian A, Hale Z, Jenny B, Lai C, Igbalode K, Wadhera D, Nair A, Ono M, Morgan J, Simpson L, Civitello A, Cheng J, Mathuria N. Incidence, predictors, and significance of ventricular arrhythmias in patients with continuous-flow left ventricular assist devices: a 15-year institutional experience. JACC Clin Electrophysiol. 2018;4(2):257–64.CrossRefGoogle Scholar
  11. 11.
    Cantillon D, Saliba W, Wazni O, Kanj M, Starling R, Tang W, et al. Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study). J Heart Lung Transplant. 2014;33(3):318–20.CrossRefGoogle Scholar
  12. 12.
    Kataria R, Jorde UP. GI bleeding during CF-LVAD support: state of the field. Cardiol Rev. 2018;27:8. Scholar
  13. 13.
    Bunte MC, Blackstone EH, Thuita L, Fowler J, Joseph L, Ozaki A, Starling RC, Smedira NG, Mountis MM. Major bleeding during HeartMate II support. J Am Coll Cardiol. 2013;62(23):2188–96.CrossRefGoogle Scholar
  14. 14.
    Izzy S, Rubin DB, Ahmed FS, Akbik F, Renault S, Sylvester KW, Vaitkevicius H, Smallwood JA, Givertz MM, Feske SK. Cerebrovascular accidents during mechanical circulatory support: new predictors of ischemic and hemorrhagic strokes and outcome. Stroke. 2018;49(5):1197–203.CrossRefGoogle Scholar
  15. 15.
    Tahsili-Fahadan P, Curfman DR, Davis AA, Yahyavi-Firouz-Abadi N, Rivera-Lara L, Nassif ME, LaRue SJ, Ewald GA, Zazulia AR. Cerebrovascular events after continuous-flow left ventricular assist devices. Neurocrit Care. 2018;29:225. Scholar
  16. 16.
    Asleh R, Hasin T, Briasoulis A, Schettle SD, Borlaug BA, Behfar A, Pereira NL, Edwards BS, Clavell AL, Joyce LD, Maltais S, Stulak JM, Kushwaha SS. Hemodynamic assessment of patients with and without heart failure symptoms supported by a continuous-flow left ventricular assist device. Mayo Clin Proc. 2018;93:895. Scholar
  17. 17.
    O’Horo JC, Abu Saleh OM, Stulak JM, Wilhelm MP, Baddour LM, Rizwan Sohail M. Left ventricular assist device infections: a systematic review. ASAIO J. 2018;64(3):287–94.CrossRefGoogle Scholar
  18. 18.
    DeVore AD, Patel PA, Patel CB. Medical management of patients with a left ventricular assist device for the non-left ventricular assist device specialist. JACC Heart Fail. 2017;5(9):621–31.CrossRefGoogle Scholar
  19. 19.
    Yoshioka D, Sakaniwa R, Toda K, Samura T, Saito S, Kashiyama N, et al. Relationship between bacteremia and hemorrhagic stroke in patients with continuous-flow left ventricular assist device. Circ J. 2018;82(2):448–56.CrossRefGoogle Scholar
  20. 20.
    Vierecke J, Schweiger M, Feldman D, Potapov E, Kaufmann F, Germinario L, Hetzer R, Falk V, Krabatsch T. Emergency procedures for patients with a continuous flow left ventricular assist device. Emerg Med J. 2017;34(12):831–41.CrossRefGoogle Scholar
  21. 21.
    Mabvuure N, Rodrigues J. External cardiac compression during cardiopulmonary resuscitation of patients with left ventricular assist devices. Interact Cardiovasc Thorac Surg. 2014;19(2):286–9.CrossRefGoogle Scholar
  22. 22.
    Peberdy M, Gluck J, Ornato J, Bermudez C, Griffin R, Kasirajan V, et al. Cardiopulmonary resuscitation in adults and children with mechanical circulatory support a scientific statement from the American Heart Association. Circulation. 2017;135(24):E1115–34.CrossRefGoogle Scholar
  23. 23.
    Ornato JP, Louka A, Grodman SW, Ferguson JD. How to determine whether to perform chest compressions on an unconscious patient with an implanted left ventricular assist device. Resuscitation. 2018;129:e12. Scholar
  24. 24.
    Rimsans J, Levesque A, Lyons E, Sylvester K, Givertz MM, Mehra MR, Stewart GC, Connors JM. Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices. J Thromb Thrombolysis. 2018;46:180. Scholar
  25. 25.
    Luc JGY, Tchantchaleishvili V, Phan K, Dunlay SM, Maltais S, Stulak JM. Medical therapy compared with surgical device exchange for left ventricular assist device thrombosis: a systematic review and meta-analysis. ASAIO J. 2018;65:307. Scholar
  26. 26.
    Loforte A, Grigioni F, Marinelli G. The risk of right ventricular failure with current continuous-flow left ventricular assist devices. Expert Rev Med Devices. 2017;14(12):969–83.CrossRefGoogle Scholar
  27. 27.
    Sayer G, Sarswat N, Kim GH, Adatya S, Medvedofsky D, Rodgers D, Kruse E, Ota T, Jeevanandam V, Lang R, Uriel N. The hemodynamic effects of aortic insufficiency in patients supported with continuous-flow left ventricular assist devices. J Card Fail. 2017;23(7):545–51.CrossRefGoogle Scholar
  28. 28.
    Dang G, Epperla N, Muppidi V, Sahr N, Pan A, Simpson P, Baumann Kreuziger L. Medical management of pump-related thrombosis in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. ASAIO J. 2017;63(4):373–85.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Emergency Medicine, Wexner Medical Center at The Ohio State UniversityColumbusUSA

Personalised recommendations